Business · World

Novo Nordisk Executive Discusses Wegovy’s Future Impact

1 sourceFirst reported 27 days agoUpdated 27 days ago

AI summary: catch up in 20 seconds

Jamey Millar addressed the CMS bridge program affecting Medicare beneficiaries.
There is uncertainty about patient volume increases post-program launch on July 1.
Novo Nordisk is focusing on provider education regarding patient eligibility.
The discussion took place during an interview on 'The Close.'

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Sign in to join the discussion.

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

Jamey Millar addressed the CMS bridge program affecting Medicare beneficiaries.
There is uncertainty about patient volume increases post-program launch on July 1.
Novo Nordisk is focusing on provider education regarding patient eligibility.
The discussion took place during an interview on 'The Close.'

Generated by AI from the 1 sources below · always verify with the originals